Warby Parker
PublicWarby Parker is now publicly traded
The data on this page reflects Warby Parker's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Sep 29, 2021
Last Round
Series G
Aug 27, 2020
Est. Valuation at Exit
$3B
Total Funding Raised
$536M
Company Overview
Warby Parker is a retail company that designs and sells prescription glasses, sunglasses, and contact lenses while offering eye exams and vision services.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Warby Parker Comparables
Compare Warby Parker with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlassesUSA.com | 80% | |
| Bloobloom | 78% | |
| DIFF Eyewear | 77% |
For institutional investors. Book with your work email.
Warby Parker Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Sep 29, 2021 | ||||
| Series G | Aug 27, 2020 | ||||
| Series F | Apr 1, 2020 | ||||
| Series E | Mar 14, 2018 | ||||
| Series D | Apr 30, 2015 | ||||
Series C | Dec 20, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Warby Parker Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Angel | Seed, Series B |
| Forerunner Ventures | Series A, Grant |
| M13 | Series G |
| Thrive Capital | Series C, Seed, Series A, Series B, Series B Extension |
| Amex Ventures | Series B |
| General Catalyst | Series C, Series D, Series B Extension, Series B |
| T. Rowe Price | Series G, Series F, Series E, Series D |
For institutional investors. Book with your work email.
Warby Parker Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.